Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | SYK | P43405 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.52 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.50 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.50 |
| ▸ | IDO1 | P14902 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | ANPEP | P15144 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | DPP4 | P27487 | 1/20 | 0.48 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.48 |
| ▸ | LTA4H | P09960 | 1/20 | 0.48 |
| ▸ | KLK7 | P49862 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29401089 | 0.99 | MAPT (0.54) | MAPTSYKMEN1KMT2AGAA | |
| SCHEMBL20168169 | 0.96 | MAPT (0.59) | MAPTSYKMEN1KMT2AGAA | |
| SCHEMBL7979181 | 0.96 | MAPT (0.59) | MAPTSYKMEN1KMT2AGAA | |
| SCHEMBL5490556 | 0.96 | MAPT (0.59) | MAPTSYKMEN1KMT2AGAA | |
| Hydrochloric Acid SCHEMBL29401553 | 0.95 | MAPT (0.58) | MAPTSYKMEN1KMT2ADPP8 | |
| SCHEMBL28251423 | 0.93 | MAPT (0.56) | MAPTSYKMEN1KMT2ADPP8 | |
| SCHEMBL28198501 | 0.93 | MAPT (0.56) | MAPTSYKMEN1KMT2ADPP8 | |
| SCHEMBL17878734 | 0.93 | SYK (0.56) | MAPTSYKMEN1KMT2AGAA | |
| SCHEMBL1021939 | 0.91 | MAPT (0.52) | MAPTSYKMEN1KMT2AGAA | |
| SCHEMBL918814 | 0.91 | MAPT (0.52) | MAPTSYKMEN1KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230270889-A1 | Fluorescently-Traceable Amino Acid Derivative And Preparation Methods And Use Thereof | Capital Medical University (CN) | 2023-08-31 | — | — | US | disclosed |
| US-10738085-B1 | Antimicrobial analogues of Gramicidin S | UNIVERSITY OF SOUTH FLORIDA (US) | 2020-08-11 | — | — | US | disclosed |
| US-10730913-B1 | Antimicrobial analogues of gramicidin S | UNIVERSITY OF SOUTH FLORIDA (US) | 2020-08-04 | — | — | US | disclosed |
| US-10351602-B1 | Antimicrobial analogues of gramicidin S | UNIVERSITY OF SOUTH FLORIDA (US) | 2019-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10730913-B1 | Antimicrobial analogues of gramicidin S | GMPS, AAAS, GNPDA1 | MAPT 4758/4885SYK 3102/4885MEN1 4579/4885 |
| US-10351602-B1 | Antimicrobial analogues of gramicidin S | GMPS, AAAS, GNPDA1 | MAPT 4758/4885SYK 3102/4885MEN1 4579/4885 |
| US-10738085-B1 | Antimicrobial analogues of Gramicidin S | GMPS, AAAS, GNPDA1 | MAPT 4758/4885SYK 3102/4885MEN1 4579/4885 |
| US-20230270889-A1 | Fluorescently-Traceable Amino Acid Derivative And Preparation Methods And Use Thereof | SLC7A5, BCAT2, BCAT1 | MAPT 3137/4885SYK 2157/4885MEN1 4025/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.